Quest Diagnostics (DGX) announced earnings for its first quarter that Increases, from last year
The company's bottom line totaled $252 million, or $2.24 per share. This compares with $220 million, or $1.94 per share, last year.
Excluding items, Quest Diagnostics reported adjusted earnings of $281 million or $2.50 per share for the period.
The company's revenue for the period rose 9.1% to $2.89 billion from $2.65 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings: $252 Mln. vs. $220 Mln. last year.-EPS: $2.24 vs. $1.94 last year.-Revenue: $2.89 Bln vs. $2.65 Bln last year.
-Guidance:Full year EPS guidance: $ 10.63 To $ 10.83Full year revenue guidance: $ 11.78 B To $ 11.90 B
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.